nemolizumab-ilto 30 MG Auto-Injector

RxCUI
2691325
RxNorm name
nemolizumab-ilto 30 MG Auto-Injector
Display name
nemolizumab-ilto 30 MG Auto-Injector
Full name
nemolizumab-ilto 30 MG Auto-Injector
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761390Nemluvionemolizumab-ilto351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NEMLUVIONEMOLIZUMAB-ILTOGalderma Laboratories, L.P.e9229ef1-ac60-4c24-afb6-009d3c7816872025-06-26Warnings, Adverse reactionsExact identifier
rxcui: 2691325

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
e9229ef1-ac60-4c24-afb6-009d3c781687nemolizumab-ilto 30 MG Auto-InjectorSCD5These highlights do not include all the information needed to use NEMLUVIO safely and effectively. See full prescribing information for NEMLUVIO. NEMLUVIO ® (nemolizumab-ilto) for injection, for subcutaneous use Initial U.S. Approval: 202420250626
e9229ef1-ac60-4c24-afb6-009d3c781687nemolizumab-ilto 30 MG Auto-InjectorPSN5These highlights do not include all the information needed to use NEMLUVIO safely and effectively. See full prescribing information for NEMLUVIO. NEMLUVIO ® (nemolizumab-ilto) for injection, for subcutaneous use Initial U.S. Approval: 202420250626